Seven-year outcomes following intensive anti-vascular endothelial growth factor therapy in patients with exudative age-related macular degeneration

por Lukacs, Regina, Schneider, Miklos, Nagy, Zoltan Zsolt, Sandor, Gabor Laszlo, Kaan, Kinga, Asztalos, Antonia, Enyedi, Lajos, Pek, Gyorgy, Barcsay, Gyorgy, Szabo, Antal, Borbandy, Agnes, Kovacs, Illes, Resch, Miklos Denes, Papp, Andras
Publicado 2023

Efficacy and Safety of the Aflibercept Biosimilar SB15 in Neovascular Age-Related Macular Degeneration: A Phase 3 Randomized Clinical Trial

por Woo, Se Joon, Bradvica, Mario, Vajas, Attila, Sagong, Min, Ernest, Jan, Studnicka, Jan, Veith, Miroslav, Wylegala, Edward, Patel, Sunil, Yun, Cheolmin, Orski, Michal, Astakhov, Sergei, Tóth-Molnár, Edit, Csutak, Adrienne, Enyedi, Lajos, Kim, Taehyung, Oh, Inkyung, Jang, Hyerin, Sadda, SriniVas R.
Publicado 2023